Pubblicazioni

Second Cancers in Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma. A Systematic Review by the Fondazione Italiana Linfomi

2022 - CANCERS

Nassi, L.; de Sanctis, V.; Loseto, G.; Gerardi, C.; Allocati, E.; Ciavarella, S.; Minoia, C.; Guarini, A.; Bari, A.

Late cardiological sequelae and long-term monitoring in classical hodgkin lymphoma and diffuse large B-cell lymphoma survivors. A systematic review by the fondazione italiana linfomi

2022 - CANCERS

Oliva, S.; Puzzovivo, A.; Gerardi, C.; Allocati, E.; De Sanctis, V.; Minoia, C.; Skrypets, T.; Guarini, A.; Gini, G.

Spatial transcriptome of a germinal center plasmablastic burst hints at MYD88/CD79B mutants-enriched diffuse large B-cell lymphomas

2022 - EUROPEAN JOURNAL OF IMMUNOLOGY

L'Imperio, Vincenzo; Morello, Gaia; Vegliante, Maria Carmela; Cancila, Valeria; Bertolazzi, Giorgio; Mazzara, Saveria; Belmonte, Beatrice; Mangogna, Alessandro; Balzarini, Piera; Corral, Lilia; Lopez, Gianluca; Di Napoli, Arianna; Facchetti, Fabio; Pagni, Fabio; Tripodo, Claudio

PET-CR as a potential surrogate endpoint in untreated DLBCL: meta-analysis and implications for clinical trial design

2022 - LEUKEMIA & LYMPHOMA

Broglio, Kristine; Kostakoglu, Lale; Ward, Carol; Mattiello, Federico; Sahin, Denis; Nielsen, Tina; Mcglothlin, Anna; Elliott, Corrine F; Witzig, Thomas; Sehn, Laurie H; TrnÄnÃ½, Marek; Vitolo, Umberto; Martelli, Maurizio; Foster, Margaret; Wendelberger, Barbara; Nowakowski, Grzegorz; Berry, Donald A

Management of relapsed or refractory large B-cell lymphoma in patients ineligible for CAR-T cell therapy

2022 - EXPERT REVIEW OF HEMATOLOGY

Perrone, Salvatore; Lopedote, Paolo; Levis, Mario; Di Rocco, Alice; Smith, Stephen Douglas